Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

被引:42
|
作者
Huguenel, ED
Cohn, D
Dockum, DP
Greve, JM
Fournel, MA
Hammond, L
Irwin, R
Mahoney, J
McClelland, A
Muchmore, E
Ohlin, AC
Scuderi, P
机构
[1] NYU, LAB EXPT MED & SURG PRIMATES, MED CTR, TUXEDO PK, NY USA
[2] WHITE SANDS RES CTR, ALAMOGORDO, NM USA
[3] BAYER CORP, BERKELEY, CA USA
关键词
D O I
10.1164/ajrccm.155.4.9105055
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intercellular adhesion molecule-1 (ICAM-1) is the cell surface receptor for the major class of human rhinoviruses, and tICAM(453), a truncated, soluble form of ICAM-1, has been shown previously to be a patent in vitro inhibitor of rhinovirus, in this report, we have investigated the in vivo efficacy of tICAM(453) for the prophylaxis of rhinovirus serotype 16 infection in the chimpanzee. Because chimpanzees do not show clinical symptoms of infection after rhinovirus challenge, infection was followed lay measuring antirhinovirus serum antibody responses and detection of virus shedding. By hath of these measures, intranasal application of tICAM(453) was efficacious in preventing rhinovirus infection in chimpanzees subsequently challenged with infectious doses of virus. These results suggest that the use of soluble rhinovirus receptor to inhibit virus binding to host cells should be feasible in humans.
引用
收藏
页码:1206 / 1210
页数:5
相关论文
共 50 条
  • [41] The relationship between soluble-intercellular adhesion molecule-1 and race/ethnicity
    Albert, MA
    Glynn, RJ
    Buring, J
    Ridker, PM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 306A - 306A
  • [42] Soluble intercellular adhesion molecule-1 in patients with recent cerebral ischemic events
    Minuk, J
    Durcan, L
    Wolfson, C
    Blinkina, A
    Mackey, A
    Lucy, V
    Berger, L
    Cote, R
    STROKE, 2001, 32 (01) : 347 - 347
  • [43] INCREASED SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN RHEUMATOID-ARTHRITIS
    KOCH, AE
    SHAH, MR
    HARLOW, LA
    LOVIS, RM
    POPE, RM
    CLINICAL RESEARCH, 1993, 41 (02): : A371 - A371
  • [44] Soluble intercellular adhesion molecule-1 in PCB and other chronic liver disease
    Welfare, MR
    Kesteven, PJL
    Hudson, M
    HEPATOLOGY, 1996, 23 (01) : P264 - P264
  • [45] Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis
    Veale, DJ
    Kirk, G
    McLaren, M
    Belch, JJF
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1227 - 1228
  • [46] Soluble intercellular adhesion molecule-1 is not predictive for patients at risk for ischemic events
    Ehrensperger, E
    Minuk, J
    Durcan, L
    Mackey, A
    Wolfson, C
    Alexandrov, L
    Fontaine, AM
    Cote, R
    STROKE, 2004, 35 (01) : 258 - 259
  • [47] Soluble intercellular adhesion molecule-1 levels in individuals with asymptomatic carotid disease
    Minuk, J
    Durcan, L
    Wolfson, C
    Mackey, A
    Berger, L
    Viera, L
    Wadup, L
    Cote, R
    STROKE, 2000, 31 (01) : 332 - 332
  • [48] Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review
    Gu, Xiaoling
    Ma, Chunyan
    Yuan, Dongmei
    Song, Yong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 36 - 44
  • [49] Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis
    Yang, SS
    Tsai, G
    Wu, CH
    Chen, DS
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 575 - 581
  • [50] INVITRO STUDIES OF THE ANTIRHINOVIRUS ACTIVITY OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1
    ARRUDA, E
    CRUMP, CE
    MARLIN, SD
    MERLUZZI, VJ
    HAYDEN, FG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) : 1186 - 1191